PHASE-1 STUDIES OF TOMUDEX (RALTITREXED) WITH PELVIC RADIOTHERAPY (RT) FOR ADJUVANT TREATMENT IN PATIENTS (PT) WITH OPERABLE RECTAL-CANCER (ORC) AND RECURRENT INOPERABLE RECTAL-CANCER (IRC)/
N. Botwood et al., PHASE-1 STUDIES OF TOMUDEX (RALTITREXED) WITH PELVIC RADIOTHERAPY (RT) FOR ADJUVANT TREATMENT IN PATIENTS (PT) WITH OPERABLE RECTAL-CANCER (ORC) AND RECURRENT INOPERABLE RECTAL-CANCER (IRC)/, British Journal of Cancer, 78, 1998, pp. 65-65